BioStem Technologies demonstrated resilience and strategic growth through increased product volume, consistent positive adjusted EBITDA, and strong gross margins. The company successfully expanded into new markets despite facing revenue and cash balance declines due to competitive pricing pressures and strategic investments.

Company Guidance

During the BioStem Technologies Third Quarter 2025 Earnings Call, CEO Jason Matuszewski and CFO Brandon Poe highlighted several key metrics and strategic initiatives. The company reported Q3 revenue of $10.5 million, down from $11 million in Q2 2025 and $18.4 million in Q3 2024, despite a 40% increase in product volume, attributed to price adjustments under the ASP Plus 6 reimbursement model. Gross profit was $9.3 million, with a gross margin of 88.5%, compared to 93.8% in the prior quarter. Operating expenses were reduced to $7.8 million from $10.2 million in Q2 2025. The company maintained a cash balance of $27.2 million at the end of Q3, supporting its strategic initiatives, including a future uplisting to NASDAQ and expansion into new markets such as Medicaid and the Department of Veteran Affairs. BioStem also reported seven consecutive quarters of positive adjusted EBITDA, underscoring its financial resilience and operational efficiency.

Increased Product Volume

Despite a challenging pricing environment, BioStem sold 40% more products on a volume basis compared to the previous quarter, indicating strong underlying demand and market share growth.

Seventh Consecutive Quarter of Positive Adjusted EBITDA

BioStem achieved its seventh consecutive quarter of positive adjusted EBITDA, highlighting the resilience and strength of its business model.

Strong Gross Margins

BioStem maintained industry-leading gross margins, with a gross profit of $9.3 million, representing a gross margin of 88.5% for Q3.

Successful FDA Inspection

BioStem's facility passed a follow-up and routine FDA inspection with no nonconformance observations, indicating a strong quality system and readiness to scale production.

Expansion into New Markets

BioStem expanded into the Medicaid market with initial success in Medi-Cal and Texas Medicaid, and partnered with a Service-Disabled Veteran-Owned Small Business to serve the VA.

BioStem Technologies (BSEM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BSEM Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Apr 06, 2026	2025 (Q4)	0.02 / -	0.17	―	―	―
Nov 13, 2025	2025 (Q3)	0.00 / 0.03	0.32	-90.63% (-0.29)	―
Aug 14, 2025	2025 (Q2)	0.32 / -0.03	0.3	-110.00% (-0.33)	―
May 12, 2025	2025 (Q1)	- / 0.27	0.2	35.00% (+0.07)	―
Apr 14, 2025	2024 (Q4)	1.25 / 0.17	0.2	-15.00% (-0.03)	―
Nov 12, 2024	2024 (Q3)	0.36 / 0.32	0.03	966.67% (+0.29)	―
Aug 12, 2024	2024 (Q2)	0.27 / 0.30	0.07	328.57% (+0.23)	―
May 14, 2024	2024 (Q1)	- / -	-0.05	―	―
Apr 01, 2024	2023 (Q4)	0.74 / 0.20	-0.05	500.00% (+0.25)	―
Nov 13, 2023	2023 (Q3)	-0.18 / 0.03	-0.14	121.43% (+0.17)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BSEM Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 13, 2025	$4.14	$3.98	-3.86%
Aug 14, 2025	$10.38	$7.04	-32.18%
May 12, 2025	$15.20	$12.63	-16.91%
Apr 14, 2025	$12.89	$10.70	-16.99%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does BioStem Technologies (BSEM) report earnings?

BioStem Technologies (BSEM) is schdueled to report earning on Apr 06, 2026, During Market Hours (Confirmed).

What is BioStem Technologies (BSEM) earnings time?

BioStem Technologies (BSEM) earnings time is at Apr 06, 2026, During Market Hours (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BSEM EPS forecast?

BSEM EPS forecast for the fiscal quarter 2025 (Q4) is 0.02.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing